Von Willebrand factor - Activity

The Von Willebrand Factor (VWF) – Activity Test from Lab Tests Dubai is a critical diagnostic toolused to evaluate the functionality of von Willebrand Factor (VWF), a key protein in your blood clotting system.

This specialized plasma-based test measures how well VWF helps platelets bind to damaged blood vessels—a crucial step in stopping bleeding. It is the gold standard for diagnosing von Willebrand Disease (VWD), the most common inherited bleeding disorder, affecting up to 1% of the population.

Using ristocetin cofactor activity (VWF:RCo) agglutination method, this test delivers highly accurate results within 10 days, making it essential for:

• Diagnosing VWD Types 1, 2, and 3
• Evaluating unexplained bleeding or bruising
• Assessing heavy menstrual bleeding (menorrhagia)
• Pre-surgical screening for bleeding risk
• Monitoring patients with family history of bleeding disorders

Available with home blood collection, Lab Tests Dubai ensures accurate, timely, and stress-free testing—so you can get answers and proper care.

Why You Need This Test

If you’re bleeding more than normal—from your nose, gums, or during your period—this test could reveal the hidden cause.

You need the VWF Activity Test if:

• You have frequent or prolonged nosebleeds (lasting >10 mins)
• You experience excessive bruising with minor bumps
• You suffer from heavy menstrual bleeding (soaking pad/tampon every hour)
• You bleed after dental work, surgery, or childbirth
• You have a family history of hemophilia or bleeding disorders
• You’re planning surgery and need bleeding risk assessment

VWD is often misdiagnosed as “just heavy periods”—but it can lead to anemia, iron deficiency, and surgical complications if untreated.

Early diagnosis = better management and safer procedures.

Symptoms That Indicate This Test

Consider the VWF Activity Test if you experience:

• For Women:

• Periods lasting more than 7 days

• Needing to change pads/tampons hourly

• Passing large blood clots

• Anemia symptoms (fatigue, dizziness)

• For All Patients:

• Nosebleeds that won’t stop without pressure

• Gums that bleed after brushing

• Unexplained bruises (large, frequent)

• Prolonged bleeding after cuts, surgery, or dental procedures

• Blood in urine or stool (rare)

• Other Indicators:

• Family history of VWD or bleeding issues

• History of iron-deficiency anemia without cause

These symptoms may point to impaired clotting—and this test provides definitive diagnosis.

Natural Production: How VWF Controls Bleeding

Von Willebrand Factor (VWF) is a large glycoprotein produced by:

• Endothelial cells (lining blood vessels)
• Megakaryocytes (platelet precursors)

It has two key roles:

1. Platelet Adhesion – Acts like “glue” to help platelets stick to injury sites
2. Carrier for Factor VIII – Protects and stabilizes this clotting protein

In von Willebrand Disease (VWD):

• Type 1 – Low levels of normal VWF (most common)
• Type 2 – VWF is present but doesn’t function properly
• Type 3 – Complete deficiency (severe bleeding risk)

This test measures VWF activity (VWF:RCo)—not just quantity—to detect functional defects.

What Happens If Untreated? Risks of Ignoring VWD

Ignoring abnormal VWF activity can lead to:

• Chronic Anemia & Iron Deficiency – from heavy periods or bleeding
• Severe Bleeding Episodes – especially after surgery or trauma
• Joint & Muscle Bleeds – in severe types (like hemophilia)
• Postpartum Hemorrhage – life-threatening after childbirth
• Unnecessary Hysterectomy – if menorrhagia is misdiagnosed

The good news? VWD is treatable with:

• Desmopressin (DDAVP) – boosts VWF release
• VWF-containing concentrates (e.g., Humate-P)
• Tranexamic acid – reduces menstrual blood loss

Early testing = fewer complications, better quality of life.

How to Prepare for the Test

To ensure accurate results:

• No fasting required

• Avoid aspirin, NSAIDs (ibuprofen), or blood thinners 5–7 days before (unless medically necessary)

• Inform your doctor of:

• Any current bleeding or infection

• Medications (especially estrogen, DDAVP, anticoagulants)

• Recent surgery or stress (can elevate VWF)

  • Avoid intense exercise 24 hours before testing

A citrate plasma sample (light blue top tube) is collected via standard draw—available at our labs or via home collection.

Test Overview: Ristocetin Cofactor Activity (Agglutination) Method

Interpretation

• <30% → Likely VWD
• 30–50% → Possible Type 1 VWD
• Low activity + low antigen → Type 1 or 3
• Low activity + normal antigen → Type 2 (qualitative defect)

Often paired with VWF Antigen, Factor VIII, and multimer analysis for full diagnosis.